Sartorius Sustainability Profile
Sartorius AG, a leading global partner of the biopharmaceutical industry, is headquartered in Göttingen, Germany. Founded in 1870, the company has evolved significantly, establishing a strong presence in Europe, North America, and Asia. Sartorius operates primarily in the life sciences and laboratory equipment sectors, focusing on bioprocess solutions and laboratory instruments. The company is renowned for its innovative products, including high-precision balances, bioreactors, and filtration systems, which are designed to enhance productivity and ensure quality in biopharmaceutical manufacturing. Sartorius has achieved notable milestones, such as its commitment to sustainability and digital transformation, positioning itself as a market leader. With a strong emphasis on research and development, Sartorius continues to drive advancements in the industry, making it a trusted name among scientists and manufacturers worldwide.
DitchCarbon Score
How does Sartorius's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sartorius's score of 86 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sartorius's reported carbon emissions
In 2024, Sartorius reported total carbon emissions of approximately 694.1 million kg CO2e, comprising 20.4 million kg CO2e from Scope 1, 28.7 million kg CO2e from Scope 2, and about 645.0 million kg CO2e from Scope 3 emissions. This represents a significant reduction from 2023, where total emissions were approximately 896.9 million kg CO2e. Sartorius has set ambitious climate commitments, aiming for climate neutrality by 2045. The company plans to reduce its Scope 1 and Scope 2 emissions to zero by 2030, which includes eliminating about 90% of emissions sources in these scopes. Additionally, Sartorius targets a 10% annual reduction in CO2 emission intensity across all scopes by 2030, using 2019 as the baseline year. The company’s initiatives reflect a strong commitment to sustainability within the pharmaceuticals, biotechnology, and life sciences sector, aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 11,044,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 18,632,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Sartorius's Industry?
How Carbon Intensive is Sartorius's Location?
Sartorius's Scope 3 Categories Breakdown
Sartorius's Scope 3 emissions, which decreased by 25% last year and decreased by approximately 27% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 41% of Scope 3 emissions.
Top Scope 3 Categories
Sartorius's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sartorius has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Thermo Fisher Scientific
GE HealthCare
Frequently Asked Questions
Common questions about Sartorius's sustainability data and climate commitments